Back to top
Read MoreHide Full Article

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

8x8, Inc. (EGHT - Free Report) : This provider of cloud-based, enterprise-class software solutions has witnessed the Zacks Consensus Estimate for its current year earnings surging 25% over the last 30 days.

8x8 Inc Price and Consensus

 

8x8 Inc Price and Consensus | 8x8 Inc Quote

Arbor Realty Trust Inc (ABR - Free Report) : This real estate investment trust has seen the Zacks Consensus Estimate for its current year earnings soaring 22.1% over the last 30 days.

Arbor Realty Trust Price and Consensus

 

Arbor Realty Trust Price and Consensus | Arbor Realty Trust Quote

ASML Holding NV (ASML - Free Report) : This manufacturer of chip-making equipment has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.7% over the last 30 days.

ASML Holding N.V. Price and Consensus

 

ASML Holding N.V. Price and Consensus | ASML Holding N.V. Quote

Bioverativ Inc (BIVV - Free Report) : This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings advancing 6.7% over the last 30 days.

BIOVERATIV INC Price and Consensus

 

BIOVERATIV INC Price and Consensus | BIOVERATIV INC Quote

Boardwalk Pipeline Partners, LP (BWP - Free Report) : This company that provides transportation, storage, gathering, and processing services for natural gas, and natural gas liquids and other hydrocarbons has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.5% over the last 30 days.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

5 Trades Could Profit ""Big-League"" from Trump Policies                                                                                                           

If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.

Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>



More from Zacks Zacks #1 Rank Additions

You May Like